APA (7th ed.) Citation

M, S., TR, C., KA, B., C, H., LA, B., AL, R., . . . AM, B. (2021). Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist. ACS medicinal chemistry letters, 12(8), 1342. https://doi.org/10.1021/acsmedchemlett.1c00363

Chicago Style (17th ed.) Citation

M, Spock, et al. "Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist." ACS Medicinal Chemistry Letters 12, no. 8 (2021): 1342. https://doi.org/10.1021/acsmedchemlett.1c00363.

MLA (9th ed.) Citation

M, Spock, et al. "Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist." ACS Medicinal Chemistry Letters, vol. 12, no. 8, 2021, p. 1342, https://doi.org/10.1021/acsmedchemlett.1c00363.